ArticleThe oncologist2025

Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers.

Caicun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.